Clinical Trial Update: Rituxan in Churg Strauss Syndrome With Renal Involvement [Phase 2]

View source ↗

Summary

A Phase 2 trial of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) with renal involvement was terminated; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Fernando Fervenza | Conditions: Churg-Strauss Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2011-12-08